|
HMGXB4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.936000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.266020E-02 |
| Normal-vs-Stage2 |
3.892500E-02 |
| Normal-vs-Stage3 |
8.722600E-01 |
| Normal-vs-Stage4 |
2.648200E-01 |
| Stage1-vs-Stage2 |
7.446600E-01 |
| Stage1-vs-Stage3 |
1.616980E-03 |
| Stage1-vs-Stage4 |
2.424200E-01 |
| Stage2-vs-Stage3 |
1.873760E-02 |
| Stage2-vs-Stage4 |
2.980000E-01 |
| Stage3-vs-Stage4 |
1.852580E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.096300E-02 |
| Normal-vs-AfricanAmerican |
9.593600E-01 |
| Normal-vs-Asian |
1.617950E-02 |
| Caucasian-vs-AfricanAmerican |
9.122300E-02 |
| Caucasian-vs-Asian |
1.315980E-01 |
| AfricanAmerican-vs-Asian |
3.881600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.902000E-02 |
| Normal-vs-Female |
9.139900E-02 |
| Male-vs-Female |
9.824400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.917600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.332000E-02 |
| Normal-vs-Age(61-80Yrs) |
9.929800E-02 |
| Normal-vs-Age(81-100Yrs) |
7.553200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.873600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.373400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.562000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.259200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.664200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.741400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.782800E-04 |
| Normal-vs-Grade 2 |
1.604730E-03 |
| Normal-vs-Grade 3 |
5.590600E-01 |
| Normal-vs-Grade 4 |
8.332400E-01 |
| Grade 1-vs-Grade 2 |
1.096800E-01 |
| Grade 1-vs-Grade 3 |
3.624300E-03 |
| Grade 1-vs-Grade 4 |
2.065700E-02 |
| Grade 2-vs-Grade 3 |
1.218170E-03 |
| Grade 2-vs-Grade 4 |
1.552240E-02 |
| Grade 3-vs-Grade 4 |
8.061000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.368120E-04 |
| Normal-vs-ccB subtype |
6.649400E-01 |
| ccA subtype-vs-ccB subtype |
1.88696999999793E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.897700E-02 |
| Normal-vs-N1 |
6.741000E-01 |
| N0-vs-N1 |
7.074800E-01 |
|
|
